Literature DB >> 19098230

Alkaline hydrolysis of mouse-adapted scrapie for inactivation and disposal of prion-positive material.

R G L Murphy1, J A Scanga, B E Powers, J L Pilon, K C Vercauteren, P B Nash, G C Smith, K E Belk.   

Abstract

Prion diseases such as bovine spongiform encephalopathy, chronic wasting disease, and scrapie pose serious risks to human and animal health due to a host of disease-specific factors, including the resistance of infectious prions (PrP(Sc)) to natural degradation and to most commercial inactivation procedures. In an attempt to address this concern, a mouse model was used to compare the efficacy of an alkaline hydrolysis process with a simulated continuous-flow rendering treatment for disposal of PrP(Sc)-infected biological material. Female C57/BL6 mice (N = 120) were randomly divided into 4 treatment groups (n = 30), and each mouse was injected intraperitoneally with their designated treatment inoculum. Treatment groups 1 and 2 served as the positive and negative controls, respectively. Group 3 was inoculated with rendered scrapie-positive mouse brain material to investigate the effectiveness of simulated continuous-flow rendering practices to reduce or eliminate PrP(Sc). Group 4 was inoculated with hydrolyzed scrapie-positive mouse brain material to determine the sterilizing effect of alkaline hydrolysis on PrP(Sc). Mice were monitored for overt signs of disease, and those showing clinical signs were killed to prevent undue suffering. Brains were obtained from all mice that died (or were killed) and analyzed with an ELISA for the presence of PrP(Sc). Results indicated that the simulated continuous-flow rendering treatment used for preparing the rendering treatment group inoculum failed to completely eliminate PrP(Sc). Rendering delayed, but did not stop, clinical mouse-adapted scrapie transmission. Compared with positive controls, the rendering treatment group experienced an approximate 45-d average delay in days to death (250 vs. 205 d for positive controls; P < 0.0001) and a death loss of 73.9% (P = 0.0094). Positive controls suffered 100% death loss. The results validated the efficacy of the alkaline hydrolysis treatment to inactivate all PrP(Sc) because no alkaline hydrolysis treatment group mice succumbed to the disease (P < 0.0001). Based on our results, alkaline hydrolysis should be considered by the animal rendering and beef packing industries as an alternative to incineration, landfill burial, and rendering for disposing of biological material potentially infected or contaminated with prion disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19098230     DOI: 10.2527/jas.2008-1492

Source DB:  PubMed          Journal:  J Anim Sci        ISSN: 0021-8812            Impact factor:   3.159


  5 in total

1.  Validation of an Autoclave Procedure for Sterilization of Mouse (Mus musculus) Carcasses.

Authors:  Marina C Pils; Katrin Kränzler; Petra Beyer; Ulrike Heise; Bastian Pasche; Hermann Riedesel
Journal:  J Am Assoc Lab Anim Sci       Date:  2018-11-06       Impact factor: 1.232

2.  Addition of exogenous α-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous α-synuclein to Lewy body and Lewy neurite-like aggregates.

Authors:  Laura A Volpicelli-Daley; Kelvin C Luk; Virginia M-Y Lee
Journal:  Nat Protoc       Date:  2014-08-14       Impact factor: 13.491

3.  Validation of the Bio-Response Solutions Human-28 Low-Temperature Alkaline Hydrolysis System.

Authors:  Gerald A Denys
Journal:  Appl Biosaf       Date:  2019-12-01

Review 4.  Treatment alternatives of slaughterhouse wastes, and their effect on the inactivation of different pathogens: a review.

Authors:  Ingrid H Franke-Whittle; Heribert Insam
Journal:  Crit Rev Microbiol       Date:  2012-06-13       Impact factor: 7.624

Review 5.  Laboratory activities involving transmissible spongiform encephalopathy causing agents: risk assessment and biosafety recommendations in Belgium.

Authors:  Amaya Leunda; Bernadette Van Vaerenbergh; Aline Baldo; Stefan Roels; Philippe Herman
Journal:  Prion       Date:  2013-09-20       Impact factor: 3.931

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.